FearLess in Cognitively Intact Patients With Glioma

This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.

Inclusion Criteria:Patient inclusion:Confirmed glioma diagnosis (grade II-IV) via histopathologyBe a minimum of 2 weeks post surgical repair or biopsy (if applicable)Elevated FCR [> 13 on Fear of Cancer Recurrence Inventory]Primarily English speakingCaregiver Inclusion:Loved one, or non-paid care partner to a patient with a confirmed glioma diagnosis (grade II-IV) via histopathologyElevated FCR [> 13 on Fear of Cancer Recurrence Inventory]Primarily English speakingAge 18+Exclusion Criteria:Patient:Cognitive impairment [< or equal to 31 on the Telephone Interview for Cognitive Status (TICS)]Inability to attend virtual sessions (e.g. due to lack of stable internet connection, difficulty using technology)Inability to understand and provide informed consent.Caregiver:Inability to attend virtual sessions (e.g. due to lack of stable internet connection, difficulty using technology)Inability to understand and provide informed consent.